Description

CJC-1295 + Ipamorelin is a research-grade peptide combination that pairs CJC-1295 (a growth hormone-releasing hormone analogue) with Ipamorelin (a selective ghrelin receptor agonist) to achieve synergistic stimulation of growth hormone (GH) secretion.

This combination is studied in preclinical and in vitro research to explore pulsatile GH release, IGF-1 production, body composition modulation, recovery, and regenerative physiology. It allows researchers to investigate both hypothalamic and pituitary mechanisms regulating GH dynamics.

For Laboratory and Scientific Research Use Only. Not for Human Consumption.

Why Researchers Choose CJC-1295 + Ipamorelin

• Dual-Pathway Stimulation: Engages both GHRH and ghrelin receptor pathways for amplified GH release.

• Pulsatile GH Secretion: Mimics natural GH pulse patterns, supporting endocrinology and metabolic research.

• Synergy with IGF-1 Studies: Enhances hepatic IGF-1 production for studies on growth, metabolism, and tissue regeneration.

• Selective & Safe Research Profile: Ipamorelin is highly selective with minimal effects on prolactin or cortisol in laboratory studies.

• Batch Verified: Co-formulated and purity-verified for reproducible research results.

Important Note

For laboratory and scientific research only. Not for human consumption, veterinary use, or diagnostic purposes.